Placing mitochondrial DNA mutations within the progression model of type I endometrial carcinoma

Human Molecular Genetics

Volumn 20, Issue 12, 2011, Pages 2394-2405

  Guerra, Flora ^a,b   Kurelac, Ivana ^b   Cormio, Antonella ^a   Zuntini, Roberta ^b   Amato, Laura Benedetta ^b   Ceccarelli, Claudio ^b   Santini, Donatella ^b   Cormio, Gennaro ^c   Fracasso, Flavio ^a   Selvaggi, Luigi ^c   Resta, Leonardo ^a   Attimonelli, Marcella ^a   Gadaleta, Maria Nicola ^a   Gasparre, Giuseppe ^b  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Obstetrics and Neonatology ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53;

ARTICLE; BIOGENESIS; CANCER CLASSIFICATION; CANCER GENETICS; CANCER GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; CTNNB1 GENE; ENDOMETRIUM CARCINOMA; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; ONCOGENE; ONCOGENE K RAS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BASE SEQUENCE; BETA CATENIN; BLOTTING, WESTERN; DISEASE PROGRESSION; DNA, MITOCHONDRIAL; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; GENOMIC INSTABILITY; HUMANS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MUTATION; PROTO-ONCOGENE PROTEINS; PTEN PHOSPHOHYDROLASE; RAS PROTEINS; SEQUENCE ANALYSIS, DNA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79957525799     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr146     Document Type: Article

References (54)

1. Brandon, M., Baldi, P. and Wallace, D.C. (2006) Mitochondrial mutations in cancer. Oncogene, 25, 4647-4662.
2. Gasparre, G., Bonora, E., Tallini, G. and Romeo, G. (2010) Molecular features of thyroid oncocytic tumors. Mol. Cell. Endocrinol., 321, 67-76.
3. Gasparre, G., Hervouet, E., de Laplanche, E., Demont, J., Pennisi, L.F., Colombel, M., Mege-Lechevallier, F., Scoazec, J.Y., Bonora, E., Smeets, R. et al. (2008) Clonal expansion of mutated mitochondrial DNA is associated with tumor formation and complex I deficiency in the benign renal oncocytoma. Hum. Mol. Genet., 17, 986-995.
4. Gasparre, G., Iommarini, L., Porcelli, A.M., Lang, M., Ferri, G.G., Kurelac, I., Zuntini, R., Mariani, E., Pennisi, L.F., Pasquini, E. et al. (2009) An inherited mitochondrial DNA disruptive mutation shifts to homoplasmy in oncocytic tumor cells. Hum. Mutat., 30, 391-396.
5. Gasparre, G., Porcelli, A.M., Bonora, E., Pennisi, L.F., Toller, M., Iommarini, L., Ghelli, A., Moretti, M., Betts, C.M., Martinelli, G.N. et al. (2007) Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors. Proc. Natl Acad. Sci. USA, 104, 9001-9006.
6. Costa-Guda, J., Tokura, T., Roth, S.I. and Arnold, A. (2007) Mitochondrial DNA mutations in oxyphilic and chief cell parathyroid adenomas. BMC Endocr. Disord., 7, 8.
7. Mayr, J.A., Meierhofer, D., Zimmermann, F., Feichtinger, R., Kogler, C., Ratschek, M., Schmeller, N., Sperl, W. and Kofler, B. (2008) Loss of complex I due to mitochondrial DNA mutations in renal oncocytoma. Clin. Cancer Res., 14, 2270-2275.
8. Zimmermann, F.A., Mayr, J.A., Neureiter, D., Feichtinger, R., Alinger, B., Jones, N.D., Eder, W., Sperl, W. and Kofler, B. (2009) Lack of complex I is associated with oncocytic thyroid tumours. Br. J. Cancer, 100, 1434-1437.
9. Ishikawa, K., Takenaga, K., Akimoto, M., Koshikawa, N., Yamaguchi, A., Imanishi, H., Nakada, K., Honma, Y. and Hayashi, J. (2008) ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science, 320, 661-664.
10. Park, J.S., Sharma, L.K., Li, H., Xiang, R., Holstein, D., Wu, J., Lechleiter, J., Naylor, S.L., Deng, J.J., Lu, J. et al. (2009) A heteroplasmic, not homoplasmic, mitochondrial DNA mutation promotes tumorigenesis via alteration in reactive oxygen species generation and apoptosis. Hum. Mol. Genet., 18, 1578-1589.
11. Shidara, Y., Yamagata, K., Kanamori, T., Nakano, K., Kwong, J.Q., Manfredi, G., Oda, H. and Ohta, S. (2005) Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis. Cancer Res., 65, 1655-1663.
12. Chatterjee, A., Mambo, E. and Sidransky, D. (2006) Mitochondrial DNA mutations in human cancer. Oncogene, 25, 4663-4674.
13. Jeronimo, C., Nomoto, S., Caballero, O.L., Usadel, H., Henrique, R., Varzim, G., Oliveira, J., Lopes, C., Fliss, M.S. and Sidransky, D. (2001) Mitochondrial mutations in early stage prostate cancer and bodily fluids. Oncogene, 20, 5195-5198.
14. Liu, V.W., Shi, H.H., Cheung, A.N., Chiu, P.M., Leung, T.W., Nagley, P., Wong, L.C. and Ngan, H.Y. (2001) High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas. Cancer Res., 61, 5998-6001.
15. Maximo, V., Soares, P., Lima, J., Cameselle-Teijeiro, J. and Sobrinho-Simoes, M. (2002) Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hurthle cell tumors. Am. J. Pathol., 160, 1857-1865.
16. Petros, J.A., Baumann, A.K., Ruiz-Pesini, E., Amin, M.B., Sun, C.Q., Hall, J., Lim, S., Issa, M.M., Flanders, W.D., Hosseini, S.H. et al. (2005) mtDNA mutations increase tumorigenicity in prostate cancer. Proc. Natl Acad. Sci. USA, 102, 719-724.
17. Gasparre, G., Romeo, G., Rugolo, M. and Porcelli, A.M. Learning from oncocytic tumors: why choose inefficient mitochondria? Biochim. Biophys. Acta, in press.
18. Hecht, J.L. and Mutter, G.L. (2006) Molecular and pathologic aspects of endometrial carcinogenesis. J. Clin. Oncol., 24, 4783-4791.
19. Matias-Guiu, X., Catasus, L., Bussaglia, E., Lagarda, H., Garcia, A., Pons, C., Munoz, J., Arguelles, R., Machin, P. and Prat, J. (2001) Molecular pathology of endometrial hyperplasia and carcinoma. Hum. Pathol., 32, 569-577.
20. Cormio, A., Guerra, F., Cormio, G., Pesce, V., Fracasso, F., Loizzi, V., Cantatore, P., Selvaggi, L. and Gadaleta, M.N. (2009) The PGC-1alpha-dependent pathway of mitochondrial biogenesis is upregulated in type I endometrial cancer. Biochem. Biophys. Res. Commun., 390, 1182-1185.
21. Czarnecka, A.M., Klemba, A., Semczuk, A., Plak, K., Marzec, B., Krawczyk, T., Kofler, B., Golik, P. and Bartnik, E. (2009) Common mitochondrial polymorphisms as risk factor for endometrial cancer. Int. Arch. Med., 2, 33.
22. Futyma, K., Putowski, L., Cybulski, M., Miotla, P., Rechberger, T. and Semczuk, A. (2008) The prevalence of mtDNA4977 deletion in primary human endometrial carcinomas and matched control samples. Oncol. Rep., 20, 683-688.
23. Wang, Y., Xue, W.C., Liu, V.W. and Ngan, H.Y. (2007) Detection of mosaic pattern of mitochondrial DNA alterations in different populations of cells from the same endometrial tumor. Mitochondrion, 7, 171-175.
24. Vogelstein, B., Fearon, E.R., Hamilton, S.R., Kern, S.E., Preisinger, A.C., Leppert, M., Nakamura, Y., White, R., Smits, A.M. and Bos, J.L. (1988) Genetic alterations during colorectal-tumor development. N. Engl. J. Med., 319, 525-532.
25. Koul, A., Willen, R., Bendahl, P.O., Nilbert, M. and Borg, A. (2002) Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis. Cancer, 94, 2369-2379.
26. Wang, Y., Liu, V.W., Ngan, H.Y. and Nagley, P. (2005) Frequent occurrence of mitochondrial microsatellite instability in the D-loop region of human cancers. Ann. NY Acad. Sci., 1042, 123-129.
27. Wang, Y., Liu, V.W., Tsang, P.C., Chiu, P.M., Cheung, A.N., Khoo, U.S., Nagley, P. and Ngan, H.Y. (2006) Microsatellite instability in mitochondrial genome of common female cancers. Int. J. Gynecol. Cancer, 16(Suppl. 1), 259-266.
28. Wong, L.J., Liang, M.H., Kwon, H., Bai, R.K., Alper, O. and Gropman, A. (2002) A cystic fibrosis patient with two novel mutations in mitochondrial DNA: mild disease led to delayed diagnosis of both disorders. Am. J. Med. Genet., 113, 59-64.
29. Liu, V.W., Wang, Y., Yang, H.J., Tsang, P.C., Ng, T.Y., Wong, L.C., Nagley, P. and Ngan, H.Y. (2003) Mitochondrial DNA variant 16189T>C is associated with susceptibility to endometrial cancer. Hum. Mutat., 22, 173-174.
30. Porcelli, A.M., Ghelli, A., Ceccarelli, C., Lang, M., Cenacchi, G., Capristo, M., Pennisi, L.F., Morra, I., Ciccarelli, E., Melcarne, A. et al. The genetic and metabolic signature of oncocytic transformation implicates HIF1alpha destabilization. Hum. Mol. Genet., 19, 1019-1032.
31. Wang, Y., Liu, V.W., Xue, W.C., Tsang, P.C., Cheung, A.N. and Ngan, H.Y. (2005) The increase of mitochondrial DNA content in endometrial adenocarcinoma cells: a quantitative study using laser-captured microdissected tissues. Gynecol. Oncol., 98, 104-110.
32. Ekstrand, M.I., Falkenberg, M., Rantanen, A., Park, C.B., Gaspari, M., Hultenby, K., Rustin, P., Gustafsson, C.M. and Larsson, N.G. (2004) Mitochondrial transcription factor A regulates mtDNA copy number in mammals. Hum. Mol. Genet., 13, 935-944.
33. Bonora, E., Porcelli, A.M., Gasparre, G., Biondi, A., Ghelli, A., Carelli, V., Baracca, A., Tallini, G., Martinuzzi, A., Lenaz, G. et al. (2006) Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III. Cancer Res., 66, 6087-6096.
34. Kong, D., Suzuki, A., Zou, T.T., Sakurada, A., Kemp, L.W., Wakatsuki, S., Yokoyama, T., Yamakawa, H., Furukawa, T., Sato, M. et al. (1997) PTEN1 is frequently mutated in primary endometrial carcinomas. Nat. Genet., 17, 143-144.
35. Konopka, B., Janiec-Jankowska, A., Czapczak, D., Paszko, Z., Bidzinski, M., Olszewski, W. and Goluda, C. (2007) Molecular genetic defects in endometrial carcinomas: microsatellite instability, PTEN and beta-catenin (CTNNB1) genes mutations. J. Cancer Res. Clin. Oncol., 133, 361-371.
36. Cohn, D.E., Basil, J.B., Venegoni, A.R., Mutch, D.G., Rader, J.S., Herzog, T.J., Gersell, D.J. and Goodfellow, P.J. (2000) Absence of PTEN repeat tract mutation in endometrial cancers with microsatellite instability. Gynecol. Oncol., 79, 101-106.
37. Sasaki, H., Nishii, H., Takahashi, H., Tada, A., Furusato, M., Terashima, Y., Siegal, G.P., Parker, S.L., Kohler, M.F., Berchuck, A. et al. (1993) Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma. Cancer Res., 53, 1906-1910.
38. Rand, A., Glenn, K.S., Alvares, C.P., White, M.B., Thibodeau, S.M. and Karnes, W.E. Jr. (1996) p53 functional loss in a colon cancer cell line with two missense mutations (218leu and 248trp) on separate alleles. Cancer Lett., 98, 183-191.
39. Simonnet, H., Demont, J., Pfeiffer, K., Guenaneche, L., Bouvier, R., Brandt, U., Schagger, H. and Godinot, C. (2003) Mitochondrial complex I is deficient in renal oncocytomas. Carcinogenesis, 24, 1461-1466.
40. Klinge, C.M. (2008) Estrogenic control of mitochondrial function and biogenesis. J. Cell. Biochem., 105, 1342-1351.
41. Mattingly, K.A., Ivanova, M.M., Riggs, K.A., Wickramasinghe, N.S., Barch, M.J. and Klinge, C.M. (2008) Estradiol st.imulates transcription of nuclear respiratory factor-1 and increases mitochondrial biogenesis. Mol. Endocrinol., 22, 609-622.
42. Smolkova, K., Plecita-Hlavata, L., Bellance, N., Benard, G., Rossignol, R. and Jezek, P. Waves of gene regulation suppress and then restore oxidative phosphorylation in cancer cells. Int. J. Biochem. Cell. Biol., in press.
43. Samarnthai, N., Hall, K. and Yeh, I.T. Molecular profiling of endometrial malignancies. Obstet. Gynecol. Int., in press.
44. Bellance, N., Lestienne, P. and Rossignol, R. (2009) Mitochondria: from bioenergetics to the metabolic regulation of carcinogenesis. Front. Biosci., 14, 4015-4034.
45. Moro, L., Arbini, A.A., Marra, E. and Greco, M. (2008) Mitochondrial DNA depletion reduces PARP-1 levels and promotes progression of the neoplastic phenotype in prostate carcinoma. Cell Oncol., 30, 307-322.
46. Moro, L., Arbini, A.A., Yao, J.L., di Sant'Agnese, P.A., Marra, E. and Greco, M. (2009) Mitochondrial DNA depletion in prostate epithelial cells promotes anoikis resistance and invasion through activation of PI3K/ Akt2. Cell Death Differ., 16, 571-583.
47. He, Y., Wu, J., Dressman, D.C., Iacobuzio-Donahue, C., Markowitz, S.D., Velculescu, V.E., Diaz, L.A. Jr., Kinzler, K.W., Vogelstein, B. and Papadopoulos, N. Heteroplasmic mitochondrial DNA mutations in normal and tumour cells. Nature, 464, 610-614.
48. Jakupciak, J.P., Maggrah, A., Maragh, S., Maki, J., Reguly, B., Maki, K., Wittock, R., Robinson, K., Wagner, P.D., Thayer, R.E. et al. (2008) Facile whole mitochondrial genome resequencing from nipple aspirate fluid using MitoChip v2.0. BMC Cancer, 8, 95.
49. Lacey, J.V. Jr., Sherman, M.E., Rush, B.B., Ronnett, B.M., Ioffe, O.B., Duggan, M.A., Glass, A.G., Richesson, D.A., Chatterjee, N. and Langholz, B. Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia. J. Clin. Oncol., 28, 788-792.
50. Attimonelli, M., Accetturo, M., Santamaria, M., Lascaro, D., Scioscia, G., Pappada, G., Russo, L., Zanchetta, L. and Tommaseo-Ponzetta, M. (2005) HmtDB, a human mitochondrial genomic resource based on variability studies supporting population genetics and biomedical research. BMC Bioinform., 6(Suppl. 4), S4.
51. Andrews, R.M., Kubacka, I., Chinnery, P.F., Lightowlers, R.N., Turnbull, D.M. and Howell, N. (1999) Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat. Genet., 23, 147.
52. van Oven, M. and Kayser, M. (2009) Updated comprehensive phylogenetic tree of global human mitochondrial DNA variation. Hum. Mutat., 30, E386-E394.
53. Akbay, E.A., Contreras, C.M., Perera, S.A., Sullivan, J.P., Broaddus, R.R., Schorge, J.O., Ashfaq, R., Saboorian, H., Wong, K.K. and Castrillon, D.H. (2008) Differential roles of telomere attrition in type I and II endometrial carcinogenesis. Am. J. Pathol., 173, 536-544.
54. Silver, S.A., Cheung, A.N. and Tavassoli, F.A. (1999) Oncocytic metaplasia and carcinoma of the endometrium: an immunohistochemical and ultrastructural study. Int. J. Gynecol. Pathol., 18, 12-19.